FI962993A0 - Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia - Google Patents

Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia

Info

Publication number
FI962993A0
FI962993A0 FI962993A FI962993A FI962993A0 FI 962993 A0 FI962993 A0 FI 962993A0 FI 962993 A FI962993 A FI 962993A FI 962993 A FI962993 A FI 962993A FI 962993 A0 FI962993 A0 FI 962993A0
Authority
FI
Finland
Prior art keywords
etanoestra
14alpha
17alpha
17beta
triene
Prior art date
Application number
FI962993A
Other languages
English (en)
Swedish (sv)
Other versions
FI962993A (fi
Inventor
Clemens Guenther
Ralph Lipp
Ulrich Taeuber
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI962993A publication Critical patent/FI962993A/fi
Publication of FI962993A0 publication Critical patent/FI962993A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
FI962993A 1994-01-27 1996-07-26 Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia FI962993A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1994/000213 WO1995020392A1 (de) 1994-01-27 1994-01-27 MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14α,17α-ETHANOESTRA-1,3,5(10)-TRIEN-3,17β-DIOL

Publications (2)

Publication Number Publication Date
FI962993A FI962993A (fi) 1996-07-26
FI962993A0 true FI962993A0 (fi) 1996-07-26

Family

ID=8165820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962993A FI962993A0 (fi) 1994-01-27 1996-07-26 Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia

Country Status (6)

Country Link
EP (1) EP0741572A1 (fi)
JP (1) JPH09510697A (fi)
AU (1) AU5971294A (fi)
FI (1) FI962993A0 (fi)
NO (1) NO963128D0 (fi)
WO (1) WO1995020392A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US20050090481A1 (en) * 2001-11-09 2005-04-28 Qlt Inc Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
CH674618A5 (fi) * 1987-04-02 1990-06-29 Ciba Geigy Ag
EP0370220B1 (de) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Mittel zur transdermalen Applikation enthaltend Gestoden
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel

Also Published As

Publication number Publication date
FI962993A (fi) 1996-07-26
NO963128L (no) 1996-07-26
NO963128D0 (no) 1996-07-26
JPH09510697A (ja) 1997-10-28
WO1995020392A1 (de) 1995-08-03
AU5971294A (en) 1995-08-15
EP0741572A1 (de) 1996-11-13

Similar Documents

Publication Publication Date Title
HUP9903515A3 (en) 21-substituted progesterone derivatives as new antiprogestational agents medicoments containing the same, use thereof
DE69511950D1 (de) Entkuppelbares selbstblockierendes Abseilgerät
HUP0002729A3 (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
HU9500354D0 (en) Antifungal agents, processes for the preparation thereof, and intermediates
FI963183A (fi) Vesipitoinen dispersiokoostumus, ja sitä käyttävä koostumus
HUP9902449A3 (en) Androstene derivatives, medicaments containing the same and their use
HUP0102415A3 (en) Oxime derivatives, intermediates, preparation thereof and agricultural chemicals containing the same
ID22228A (id) Turunan-turunan 16-hidroksi-11-(disubstitusifenil)-estra-4,9-diena
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
DE59800439D1 (de) Vernetzbare, in Wasser redispergierbare Pulverzusammensetzung
ATE348836T1 (de) Neue 3,6-hemiketale der 9a-azalidklasse
ES1025468Y (es) "valvula mezcladora monomando, perfeccionada"
DE69811651D1 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
FI962993A0 (fi) Ihon läpi tapahtuvaan antoon tarkoitettu väline, joka sisältää 14alfa,17alfa-etanoestra-1,3,5(10)-trieeni-3,17beta-diolia
FI952993A0 (fi) Ilmentämisjärjestelmä, intergraatiovektori ja tällä integraatioverkolla transformoitu solu
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DK0973790T3 (da) Estra-5(10),7-diener med østrogen aktivitet
ID20352A (id) Bahan herbisida 3,5-difluoropiridin
FR2727965B1 (fr) 4,4'-(phenylenediisopropyl )-bis- (2.6-dialkylphenylisocyanates)
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
ATE219042T1 (de) Insektizide und akarizide 1,4-diaryl-2,3-difluor- 2-butene
HUP0101911A3 (en) Novel sequence class of genes, corresponding proteins and the use of the same
ES1028973Y (es) Cuaderno perfeccionado de uso infantil.
BR7400004U (pt) Disposição em mosquetão

Legal Events

Date Code Title Description
FD Application lapsed